Title |
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2− breast cancer resistant to endocrine therapy: VinoMetro—AGO-B-046 |
|---|---|
Involved |
Slavomir Krajnak (Verfasser)
Thomas Decker (Verfasser) Lukas Schollenberger (Verfasser) Christian Rosé (Verfasser)
Christian Ruckes (Verfasser)
Tanja Fehm (Verfasser) Christoph Thomssen (Verfasser) Nadia Harbeck (Verfasser) Marcus Schmidt (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Journal of cancer research and clinical oncology : official organ of the Deutsche Krebsgesellschaft 20.3.2021, Seite 1-10 |
Published |
2021 |
Language |
|
Country |
|
Topic |
|
Subject |
Oncology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2021050616431940937138 (URN) |
Record ID |
1232982415 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: